Scientists Break Blood-Brain Barrier to Allow Cancer Drugs In
News Oct 15, 2013
The study, in mice and tissue samples, used a protein called TNF that can track down sites in the brain where cancer has spread by recognising a marker found only on tumour blood vessels.
The researchers found that TNF can home in on these sites and temporarily open the blood-brain barrier (BBB) allowing drugs to pass from the blood system into the tumour.
The BBB acts as a shield that prevents potentially dangerous particles such as bacteria entering the brain. But it's this same shield that stops cancer drugs reaching tumours that have spread to the brain.
The TNF protein only broke down the BBB in the blood vessels that pass through the tumour, leaving the healthy parts of the brain undamaged by potentially toxic drugs.
The research showed that when TNF is injected into the bloodstream, the breast cancer drug herceptin (trastuzumab) – which is not normally able to cross the BBB – can reach cancer cells in the brain.
The research is reported in the Journal of the National Cancer Institute.
Dr Nicola Sibson of the Department of Oncology at the University of Oxford said: 'Treatments that work very well against the original site of the cancer lose their effectiveness when the cancer spreads to the brain – as these drugs are prevented from getting to the tumour because of the blood-brain barrier.
'A number of attempts have been made to open up the BBB but they've all struggled because they're either not specific enough to open the BBB only at the site of the tumour or not effective enough to allow the drug across to kill the cancer.'
Dr Kat Arney, science information manager at Cancer Research UK, which funded the work, said: 'Getting treatments through the blood-brain barrier remains one of the greatest challenges for cancer researchers. This exciting result points the way to a potentially game-changing moment in finding ways to treat cancers that have spread to the brain. We now need to test this approach in cancer patients to see if it will have the same effect.'
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Techniques for Mammary Gland Research
Mar 05 - Mar 09, 2018